choline has been researched along with Diffuse Lymphocytic Lymphoma, Poorly-Differentiated in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abeykoon, JP | 1 |
| Wu, X | 1 |
| Nowakowski, KE | 1 |
| Dasari, S | 1 |
| Paludo, J | 1 |
| Weroha, SJ | 1 |
| Hu, C | 1 |
| Hou, X | 1 |
| Sarkaria, JN | 1 |
| Mladek, AC | 1 |
| Phillips, JL | 1 |
| Feldman, AL | 1 |
| Ravindran, A | 1 |
| King, RL | 1 |
| Boysen, J | 1 |
| Stenson, MJ | 1 |
| Carr, RM | 1 |
| Manske, MK | 1 |
| Molina, JR | 1 |
| Kapoor, P | 1 |
| Parikh, SA | 1 |
| Kumar, S | 1 |
| Robinson, SI | 1 |
| Yu, J | 1 |
| Boughey, JC | 1 |
| Wang, L | 1 |
| Goetz, MP | 1 |
| Couch, FJ | 1 |
| Patnaik, MM | 1 |
| Witzig, TE | 1 |
1 other study available for choline and Diffuse Lymphocytic Lymphoma, Poorly-Differentiated
| Article | Year |
|---|---|
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Checkpoints; Choline; DNA Repair | 2021 |